Clinical Trial Update: Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT) [Phase 4]

View source ↗

Summary

Phase 4 study assessing the efficacy and safety of combining denosumab with eldecalcitol for osteoporosis in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Eldecalcitol (eldecalcitol)

Snippet

Sponsor: Xi'an Honghui Hospital | Conditions: Osteoporosis in Postmenopausal Women | Phase 4 | Status: COMPLETED